Guardant Health
GH
41,27 €
Share price
-1.56%
Change (1 day)
148.46%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
EPS for Guardant Health (GH)
EPS in 2023 (TTM): -4,68 €
According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -4,56 €. In 2022 the company made an earnings per share (EPS) of -5,94 € a decrease over its 2021 EPS that were of -3,71 €.
EPS history for Guardant Health from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -4,68 € | -21.18% |
| 2022 | -5,94 € | 60% |
| 2021 | -3,71 € | 55.04% |
| 2020 | -2,40 € | 207.14% |
| 2019 | -0,78 € | -19.81% |
| 2018 | -0,97 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -4,48 € | -1.83% | 🇺🇸 USA |
 | -0,11 € | -97.57% | 🇺🇸 USA |